Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Leukemia
Leukemia
,
Oncology
New Targeted Agent Shows Significant Success in Treating Refractory Form of AML
Wayne Kuznar
Read More
Leukemia
,
Oncology
Novel Agents Will Completely Change CLL Treatment
Read More
Leukemia
,
Oncology
Bendamustine Outperforms R-CHOP in NHL
Read More
Leukemia
,
Oncology
Bosutinib Shows Superior Results in CML
Neil Canavan
,
Neil Canavan
Read More
Leukemia
,
Oncology
Novel Oral B-Cell Receptor Inhibitor Very Effective in Chronic Lymphocytic Leukemia
Caroline Helwick
,
Caroline Helwick
,
Caroline Helwick
Read More
Leukemia
,
Oncology
Obinutuzumab Could Give Rituximab a Run for Its Money in Relapsed Indolent NHL
Read More
Leukemia
,
Oncology
Maintenance Rituximab May Be Unnecessary in FL
Caroline Helwick
,
Caroline Helwick
Read More
Leukemia
,
Oncology
Investigational Blinatumomab Puts BiTE on Acute Lymphoblastic Leukemia
Neil Canavan
Read More
Leukemia
,
Oncology
Ponatinib Overcomes Hard-to-Treat T315I Mutation in Patients with CML/ALL
Neil Canavan
,
Neil Canavan
Read More
Leukemia
,
Oncology
High-Dose Methotrexate Improves Survival in High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia
Read More
4
5
6
7
Page 7 of 7
Results 61 - 70 of 70